Invention Grant
- Patent Title: Heteroaryl inhibitors of PDE4
-
Application No.: US17808439Application Date: 2022-06-23
-
Publication No.: US11767334B2Publication Date: 2023-09-26
- Inventor: Mark E. Gurney , Timothy J. Hagen , Xuesheng Mo , A. Samuel Vellekoop , Donna L. Romero , Robert Campbell , Joel R. Walker , Lei Zhu
- Applicant: Tetra Discovery Partners, LLC
- Applicant Address: US MI Grand Rapids
- Assignee: Tetra Discovery Partners, LLC
- Current Assignee: Tetra Discovery Partners, LLC
- Current Assignee Address: US MI Grand Rapids
- Agent Cynthia Hathaway; C. A. Schlecht
- The original application number of the division: US14349688
- Main IPC: A61K31/4418
- IPC: A61K31/4418 ; C07F5/02 ; C07D213/72 ; C07D403/12 ; C07D413/14 ; C07D213/74 ; C07D221/04 ; C07D409/04 ; C07D409/14 ; C07D413/12 ; C07D495/04 ; C07D213/56 ; A61K45/06 ; A61K31/435 ; A61K31/505 ; A61K31/517 ; A61K31/53 ; A61K31/69 ; C07D239/26 ; C07D239/70 ; C07D251/22 ; C07D401/12 ; C07D405/04 ; A61K31/44 ; A61K31/496 ; A61K31/506 ; A61K31/519 ; A61K31/5377 ; C07D251/30 ; C07D251/42 ; C07D401/04
Abstract:
The present invention relates to compounds and methods useful as inhibitors of phosphodiesterase 4 (PDE4) for the treatment or prevention of inflammatory diseases and other diseases involving elevated levels of cytokines and proinflammatory mediators.
Public/Granted literature
- US20230024240A1 HETEROARYL INHIBITORS OF PDE4 Public/Granted day:2023-01-26
Information query
IPC分类:
